Australia paves the way for more humane care with therapeutic cannabis
Research shows that most Australians support the integration of therapeutic cannabis into the healthcare system
Amid an increasingly open debate about well-being and quality of life, Australia shows signs that the population already sees therapeutic cannabis as a natural part of the future of health.
According to the website Cáñamo, a new survey shows that public support is growing rapidly and is helping to drive important changes in the country.
The research indicates that 64% of Australians believe that medicinal cannabis should be fully integrated into the traditional healthcare system. More than that: 66% of respondents say they trust that their doctors are prepared to use the plant in specific treatments, reinforcing the perception that the topic has already surpassed the taboo phase and is advancing into the realm of responsible clinical practice.
Another noteworthy point is the role of telemedicine. According to the website Cáñamo, 94% of the population sees remote consultations as an essential gateway to expanding access to treatments, especially in areas far from major centers.
For 75% of participants, teleconsultation facilitates access to healthcare as a whole, and about one-third believe that this type of service will be predominant in the coming years.
A new perspective on care
For Nicole Le Maistre, CEO of Leafio, the data shows an important cultural shift. She highlights that patients are seeking more flexibility in consultations, home delivery of medications, and autonomy over their treatments, factors that, according to the website, have strengthened the conversation about regulating cannabis safely and transparently.
Regulation debates continue to evolve
Despite the optimism, the study also points out concerns among healthcare professionals. Experts warn of the risks of models with excessive prescriptions and advocate for more balance between access and clinical rigor. In this scenario, the Australian government is already evaluating new regulatory revisions, seeking to adapt the rules to the market reality and the needs of patients.
With information from Cañamo.Net.